NCT01897012 2019-01-28Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasNational Cancer Institute (NCI)Phase 1 Completed26 enrolled
NCT00077194 2013-02-11FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Completed35 enrolled